fig1

Figure 1. Technetium-99m 3,3-diphosphono-1,2-propanodicarboxylic acid bone scan shows a carrier patient with Ala36Pro, visual score 3 with spleen uptake in 2014. After five years, the patient developed cardiac amyloidosis (hATTR CA).